Top 18 Day One Biopharmaceuticals investors
The most complete profiles first. Showing 18 of 18.
Eric YoungVerified
Venture Capital, Founder, Investor · United Kingdom
SeedSeries BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Filanet, Hallo and 85 more
Verified email available
Guy RussoVerified
Venture Capital, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jared NewmanVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Joydeep BhattacharyyaVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceCybersecurityPortfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Laura ChauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Tim ShannonVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 83 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Hootan RashidifardVerified
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Dan BeckerVerified
Venture Capital, Design Operator, Advisor · United States
SeedPre-SeedHealth CareRemote Work TechE-commercePaymentsPortfolio: Square, Strava, Almanac Beer Company, Neurana Pharmaceuticals and 3 more
Verified email available
Nandu Anilal
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Rayfe Gaspar
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Byron Ling
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Norman Zhou
Venture Capital · United States
Health CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Vivace Therapeutics11
- Tyra Biosciences11
- Astra10
- Nocion Therapeutics10
- Taptap Send10
- Apex.AI10
- Synthekine10
- Ladder10
- Sounding Board10
- Sleek10
- Vineti10
Frequently asked questions
How many Day One Biopharmaceuticals investors are on Angel Roster?
Angel Roster lists 18 Day One Biopharmaceuticals investors. 12 of them (67%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (7) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Day One Biopharmaceuticals investors invest in?
Among those that list a stage, the most common are Series B (10), Series A (8) and Seed (2).
Where are Day One Biopharmaceuticals investors based?
Most are based in the United States (17) and the United Kingdom (1).
Which companies have Day One Biopharmaceuticals investors backed?
The most-backed portfolio companies among them are Vivace Therapeutics (11), Tyra Biosciences (11), Astra (10), Nocion Therapeutics (10) and Taptap Send (10).
How do I contact Day One Biopharmaceuticals investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.